Skip to main content

Day: May 25, 2023

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

5 new patent grants, 3 expected upcoming patent grants, and 8 notices of allowance in key international jurisdictions LONDON, May 25, 2023 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces an update to its intellectual property (“IP“) portfolio, demonstrating significant progress already made by the Company in 2023. Small Pharma aims to protect its pipeline programs through a multi-layered IP strategy with four core areas of protection. These areas of protection include: Composition of Matter, covering novel drug substances; Medical Use, covering therapeutic compositions and medical uses thereof; Drug Product, covering pharmaceutical formulations;...

Continue reading

Form 8.3 – [EMIS Group plc – 24 05 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Auriant Mining AB (publ.) announces termination of the liquidity provider agreement

Auriant Mining AB (publ.) (the “Company”) has today terminated the agreement with Mangold Fondkommission AB (“Mangold”) on the assignment as liquidity provider.  The last day of provision of liquidity support by Mangold will be August 25, 2023.  The termination of the liquidity provider agreement is a result of the execution of the Company’s  strategy, which includes ongoing optimization of the Company’s costs. For more information please contact: Danilo Lange, CEOTel: +7 495 109 02 82E-mail: d.lange@auriant.com Company name: Auriant Mining ABShort name: AURISIN-code: SE0001337213 Website: www.auriant.com Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including...

Continue reading

Northland Power Announces Sale of its 49 Per Cent Interest in the Nordseecluster Offshore Wind Projects to its Partner, RWE

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated September 7, 2022, to its short form base shelf prospectus dated June 16, 2021. TORONTO, May 25, 2023 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “company”) (TSX: NPI) announces the sale of its full 49 per cent ownership stake in the Nordseecluster offshore wind portfolio (NSC) to its partner on the portfolio, RWE Offshore Wind GmbH (RWE). The sale provides RWE with 100 per cent ownership of the projects for a cash consideration of approximately EUR 35 million, which represents a premium to Northland’s costs incurred to date. This transaction will transfer the assets and liabilities, and all committed contractual obligations of Northland in relation to NSC, to RWE. NSC’s total gross capacity comprises...

Continue reading

Draganfly to Showcase First Responder Drone Technology at the 2023 Texas Emergency Management Conference

Los Angeles, CA., May 25, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that the Company will be featured at the 2023 Texas Emergency Management Conference. The conference will be held at the Fort Worth Convention Center in Fort Worth, Texas, from May 30 to June 2, 2023. The Texas Emergency Management Conference connects over 3,000 elected officials, first responders, emergency managers, and decision-makers from across the U.S. Attendees can participate in key workshops and check out innovative products and services from various organizations. Draganfly will showcase its Drone as First Responder (“DFR”), Heavy Lift, and Commander 3 XL Drone platforms and Vital Intelligence...

Continue reading

GDS Holdings Limited Reports First Quarter 2023 Results

SHANGHAI, China, May 25, 2023 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial HighlightsNet revenue increased by 7.4% year-over-year (“Y-o-Y”) to RMB2,409.0 million (US$350.8 million) in the first quarter of 2023 (1Q2022: RMB2,243.6 million). Service revenue increased by 7.4% Y-o-Y to RMB2,408.4 million (US$350.7 million) in the first quarter of 2023 (1Q2022: RMB2,243.5 million). Net loss was RMB474.6 million (US$69.1 million) in the first quarter of 2023 (1Q2022: net loss of RMB373.3 million). Adjusted EBITDA (non-GAAP) increased by 7.5% Y-o-Y to RMB1,130.0...

Continue reading

Resolutions of the annual general meeting of Hepsor AS

The annual general meeting of shareholders of Hepsor AS (registry code 12099216, address Järvevana 7b, 10112 Tallinn) was held on Thursday, 25 May 2023 at 11:00 in the conference hall of L’Embitu Hotel at Lembitu 12, Tallinn. The notice of convening the ordinary general meeting of shareholders was published on 3 May 2023 in the newspaper Postimees and on 2 May 2023 as a stock exchange news through the information system of Nasdaq Tallinn Stock Exchange. Therefore, the meeting was duly convened. The list of shareholders eligible to participate at the ordinary general meeting of shareholders was fixed 7 (seven) days before holding the meeting, i.e. on 18 May 2023 at the end of the working day of the settlement system of Nasdaq CSD SE. As at the date of fixing the list of shareholders, Hepsor AS has altogether 11 440 shareholders who hold...

Continue reading

Lincoln Electric Awarded on the USA Today America’s Climate Leaders 2023 List

CLEVELAND, May 25, 2023 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) is pleased to announce that it has been awarded on the USA Today list of America’s Climate Leaders 2023. This inaugural award is presented by USA Today and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list can be viewed on the USA Today website. USA Today’s America’s Climate Leaders 2023 List represents the leading 400 companies across the United States that achieved the greatest reduction in their core emissions intensity between 2019 and 2021, as calculated by their Scope 1 and 2 greenhouse gas emissions as a ratio of revenue. Lincoln Electric was one of 31 companies awarded within the Capital Goods category. “We are pleased to be named as one of America’s Climate Leaders,...

Continue reading

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101

– Initial Data from Global, Multiple Ascending Dose Phase 1/2 ACHIEVE Clinical Trial in Myotonic Dystrophy Type 1 Anticipated in the Second Half of 2023 – WALTHAM, Mass., May 25, 2023 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that the European Medicines Agency (EMA) has granted orphan drug designation for DYNE-101. DYNE-101 is being evaluated in the Phase 1/2 ACHIEVE global clinical trial in adults with myotonic dystrophy type 1 (DM1). “We are pleased to receive orphan drug designation from the EMA for DYNE-101, further supporting our efforts to develop a potentially transformative therapy for DM1,” said Wildon Farwell, M.D., MPH, chief...

Continue reading

CSW Industrials Reports Record Fiscal 2023 Fourth Quarter and Full Year Results

DALLAS, May 25, 2023 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI or the “Company”) today reported record results for the fiscal 2023 fourth quarter and full year periods ended March 31, 2023. Fiscal 2023 Fourth Quarter Highlights (comparisons to fiscal 2022 fourth quarter)Total revenue increased 12.9% to $195.7 million, with an organic growth rate of 10.5% Net income attributable to CSWI increased 46.7% to $27.1 million, compared to $18.4 million, with no adjustments to earnings in either period Earnings per diluted share (EPS) increased 48.7% to $1.74, compared to $1.17 EBITDA increased 32.8% to $49.4 million, with margin expansion of 370 bps to 25.2% Paid down $23.5 million of debt and improved balance sheet strength with a leverage ratio (Debt to EBITDA), in accordance with our credit facility, of approximately...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.